Stryker (SYK) Other Non-Current Liabilities (2009 - 2026)
Stryker (SYK) posted quarterly Other Non-Current Liabilities of $2.7 billion for Q2 2026, up 1.22% year-over-year from $2.6 billion in Q2 2025, and up 12.24% on a QoQ basis from $2.4 billion in Q1 2026.
Stryker (SYK) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Stryker has reported Other Non-Current Liabilities for 18 years, with the latest figure at $2.7 billion in Q2 2026.
- Other Non-Current Liabilities for Q2 2026 came in at $2.7 billion, up 1.22% year-over-year; the trailing twelve-month figure through Jun 2026 was $2.7 billion (up 1.22% YoY), and the FY2025 annual result was $2.4 billion, up 8.47% from the prior year.
- Other Non-Current Liabilities advanced to $2.7 billion in Q2 2026, from $2.4 billion in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $2.7 billion in Q2 2026 and troughed at $1.5 billion in Q4 2022.
- A 5-year average of $2.1 billion and a median of $1.9 billion in 2023 frame the typical range for Other Non-Current Liabilities.
- The widest annual swing landed in 2022, when Other Non-Current Liabilities declined 19.54%; it then surged 33.74% in 2025.
- A 5-year view of Other Non-Current Liabilities shows it stood at $1.5 billion in 2022, then soared by 31.56% to $1.9 billion in 2023, then increased by 13.16% to $2.2 billion in 2024, then advanced by 8.47% to $2.4 billion in 2025, then rose by 12.28% to $2.7 billion in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $2.7 billion in Q2 2026, $2.4 billion in Q1 2026, and $2.4 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.66 Bn |
| Mar 31, 2026 | 2.37 Bn |
| Dec 31, 2025 | 2.37 Bn |
| Sep 30, 2025 | 2.61 Bn |
| Jun 30, 2025 | 2.63 Bn |
| Mar 31, 2025 | 372.00 Mn |
| Dec 31, 2024 | 349.00 Mn |
| Sep 30, 2024 | 368.00 Mn |
| Jun 30, 2024 | 1.97 Bn |
| Mar 31, 2024 | 1.90 Bn |
| Dec 31, 2023 | 567.00 Mn |
| Sep 30, 2023 | 1.83 Bn |
| Jun 30, 2023 | 1.85 Bn |
| Mar 31, 2023 | 1.59 Bn |
| Dec 31, 2022 | 1.47 Bn |
| Sep 30, 2022 | 1.58 Bn |
| Jun 30, 2022 | 1.79 Bn |
| Mar 31, 2022 | 917.00 Mn |
| Dec 31, 2021 | 913.00 Mn |
| Sep 30, 2021 | 1.96 Bn |